Hepatic injury and COVID-19: pathogenic mechanisms or epiphenomena?


Journal

Revista espanola de enfermedades digestivas
ISSN: 1130-0108
Titre abrégé: Rev Esp Enferm Dig
Pays: Spain
ID NLM: 9007566

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 12 2 2021
medline: 24 7 2021
entrez: 11 2 2021
Statut: ppublish

Résumé

Ampuero J et al. analyzed the relationship between liver injury and clinical progression of the disease in a meta-analysis of over 5,000 COVID-19 patients. The authors reported an association between increased aspartate aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin levels with mortality, admission to Intensive Care and the development of complications, respectively.

Identifiants

pubmed: 33569967
doi: 10.17235/reed.2021.7851/2021
doi:

Substances chimiques

Aspartate Aminotransferases EC 2.6.1.1
Alanine Transaminase EC 2.6.1.2

Types de publication

Letter Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

554-555

Commentaires et corrections

Type : CommentOn

Auteurs

Javier A Cienfuegos (JA)

Cirugía/Apoyo Investigación, Clinica Universidad de Navarra, España.

Víctor Valentí (V)

General Surgery, Clínica Universidad de Navarra, España.

Fernando Rotellar (F)

General Surgery, Clínica Universidad de Navarra, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH